Singular Genomics Systems, Inc. (OMIC) DCF Valuation

Singular Genomics Systems, Inc. (OMIC) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Singular Genomics Systems, Inc. (OMIC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (OMIC) DCF Calculator enables you to evaluate Singular Genomics Systems, Inc. valuation using up-to-date financial data while providing comprehensive flexibility to modify all key parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .8 2.9 3.6 4.5 5.7 7.1 8.9
Revenue Growth, % 0 0 0 0 280.52 25 25 25 25 25
EBITDA -12.0 -26.4 -60.5 -84.1 -86.5 .7 .9 1.1 1.4 1.8
EBITDA, % 100 100 100 -10991.37 -2971.35 20 20 20 20 20
Depreciation .4 .6 1.1 6.0 7.2 3.6 4.5 5.7 7.1 8.9
Depreciation, % 100 100 100 788.5 248.13 100 100 100 100 100
EBIT -12.3 -27.0 -61.7 -90.1 -93.7 .7 .9 1.1 1.4 1.8
EBIT, % 100 100 100 -11779.87 -3219.48 20 20 20 20 20
Total Cash 46.2 26.9 339.2 244.6 173.9 3.6 4.5 5.7 7.1 8.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 1.1 2.0 1.6
Account Receivables, % 100 100 100 263.01 54.41
Inventories .0 .0 3.0 18.2 13.6 3.6 4.5 5.7 7.1 8.9
Inventories, % 100 100 100 2381.83 466.23 100 100 100 100 100
Accounts Payable .6 .4 2.3 3.1 2.6 3.6 4.4 5.6 6.9 8.7
Accounts Payable, % 100 100 100 405.1 88.87 97.77 97.77 97.77 97.77 97.77
Capital Expenditure -.8 -1.4 -4.9 -6.0 -1.0 -1.0 -1.2 -1.5 -1.9 -2.4
Capital Expenditure, % 100 100 100 -787.19 -33.32 -26.66 -26.66 -26.66 -26.66 -26.66
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -12.3 -27.7 -61.8 -87.5 -93.7 .7 .9 1.1 1.4 1.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.2 -28.6 -67.6 -102.9 -82.9 12.6 3.4 4.2 5.3 6.6
WACC, % 7.22 7.22 7.22 7.14 7.22 7.2 7.2 7.2 7.2 7.2
PV UFCF
SUM PV UFCF 26.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 7
Terminal Value 130
Present Terminal Value 92
Enterprise Value 119
Net Debt 59
Equity Value 60
Diluted Shares Outstanding, MM 2
Equity Value Per Share 24.55

What You Will Get

  • Real OMIC Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Singular Genomics Systems, Inc.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to [OMIC].
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Singular Genomics' fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for [OMIC].
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Singular Genomics Systems, Inc.

Key Features

  • Comprehensive Genomic Analysis Tools: Offers advanced tools for sequencing and data analysis tailored for genomic research.
  • Customizable Bioinformatics Solutions: Pre-configured bioinformatics pipelines with options for user-defined parameters.
  • Flexible Data Integration: Easily integrate various data types, including genomic, transcriptomic, and proteomic data.
  • Built-In Analytical Metrics: Evaluate key performance indicators for genomic data interpretation.
  • User-Friendly Dashboard: Interactive visualizations provide a clear overview of genomic insights and trends.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Singular Genomics Systems, Inc.'s preloaded data.
  • 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Assurance: Share professional valuation insights to bolster your decision-making process.

Why Choose This Calculator for Singular Genomics Systems, Inc. (OMIC)?

  • Accurate Data: Utilize real financials from Singular Genomics for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Ready-made calculations save you the effort of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: An intuitive design and clear step-by-step guidance make it accessible for all users.

Who Should Use This Product?

  • Investors: Evaluate Singular Genomics' (OMIC) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for accuracy.
  • Biotech Entrepreneurs: Understand the valuation strategies of leading genomic companies like Singular Genomics.
  • Consultants: Provide comprehensive valuation analyses and reports for biotechnology clients.
  • Students and Educators: Utilize current genomic industry data to learn and teach valuation practices.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Singular Genomics Systems, Inc. (OMIC).
  • Real-World Data: Singular Genomics’ historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Interactive charts and tables for clear, actionable results.

No products were found matching.